Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Pharmacies to get more ...

    Pharmacies to get more power to give Drugs without Prescriptions

    Written by Ruby Khatun Khatun Published On 2017-09-20T21:02:45+05:30  |  Updated On 2021-08-18T14:17:24+05:30

    New Delhi: The Central Drugs Standard Control Organization (CDSCO) is planning to introduce provisions in the Drugs and Cosmetics rules to allow pharmacists to give drugs for minor conditions and adjust dosages accordingly without doctor's prescription in order to save patients to visit their doctor for every common ailment.


    A new category of over the counter drugs (OTC) has proposed by the drug regulator which will be empowered the pharmacists to dispense the medicines without doctor's prescription. The OTC drugs will be consist of anti-allergies, antipyretic (for fever), antiemetic (for vomiting and nausea), muscle relaxants, decongestants (for a cough and cold), anti-inflammatory drugs, antacids, external preparations for skin and hormonal contraceptives. There are some restrictions also pharmacists will not be allowed to prescribe habit-forming drugs or strong antibiotics.


    The proposed provision will be discussed at the drugs consultative committee (DCC) meeting which will be chaired by the Drug Controller General of India (DCGI) and attended by state drug controllers from all across India.


    A special provision to include OTC medicines in the Drugs and Cosmetics rules has been proposed. If approved by DCC, the matter will be taken up by the government's chief advisory body on drugs—the Drugs Technical Advisory Board (DTAB)—next month and will then be sent to the Union health ministry for final notification, according to the DCC agenda, reviewed by Mint.


    LiveMint reports that over-the-counter drugs are common in many countries. Currently, in India allopathic drugs which are safe to be dispensed mostly fall under Schedule H and H1 and require a prescription. "As per Drug & Cosmetic Act, 1940 and thereunder Rules 1945, these drugs should be sold by prescription only. The new proposal, therefore, will make it easier for people to get these drugs hassle-free," said a senior official told the daily, privy to the development requesting anonymity.


    Kailash Gupta, president, All India Chemists and Distributors Federation, said, "The expanded powers will have several advantages including increased convenience and accessibility for those who need refills or have a minor condition. The patients will be able to cut down on doctor's consultation fees and the improved ability of the pharmacist to help manage a patient's long-term care will help alleviate pressure on hospital emergency rooms and doctor's offices."


    "Other benefits include the ability of pharmacists to prescribe drugs in times of emergency and assist patients who don't have a family doctor," he added.

    CDSCO Central Drugs Standard Control Organization Drug Controller General of India drugs OTC over-the-counter Pharmacies 
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      After Abbott, two more Stent makers seek withdrawal of New Gen Stents

      After Abbott, two more Stent makers seek withdrawal of New Gen Stents

      3.36% of about 82,600 drugs samples found to be substandard

      3.36% of about 82,600 drugs samples found to be substandard

      Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial

      Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial

      Sterling Biotech Bank Fraud: ED seize assets including business jet, ships, oil rings worth over Rs 9700 crore

      Sterling Biotech Bank Fraud: ED seize assets including business jet, ships, oil rings worth over Rs...

      Apollo medical centre in Oman granted hospital status

      Apollo medical centre in Oman granted hospital status

      Calcutta HC sets aside Centers decision for strategic sale of Bengal Chemicals

      Calcutta HC sets aside Center's decision for strategic sale of Bengal Chemicals

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

      Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

      View All

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 27 May 2022 6:45 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
      verify here.

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
      X
      X